News
- Author:
- Will Pass
Publish date: December 19, 2019
In TIVO-3, a phase 3 trial involving 350 patients with metastatic RCC who had been treated with two or more systemic therapies, patients in the tiv...
News
- Author:
- Will Pass
Publish date: December 17, 2019
SAN ANTONIO - Among patients with TNBC who were treated with weekly nab-paclitaxel, 60.4% achieved pCR, compared with 50.0% who were treated with n...
News
- Author:
- Will Pass
Publish date: December 14, 2019
SAN ANTONIO – Results from large meta-analysis are expected to alter the American Joint Committee on Cancer (AJCC) staging standards in breast canc...
News
- Author:
- Will Pass
Publish date: December 13, 2019
The machine learning validation study was based on two previous case-control trials, BEST2 and BOOST.
News
- Author:
- Will Pass
Publish date: December 13, 2019
SAN ANTONIO - In a phase 3 trial of 585 women with triple-negative breast cancer, 5-year disease free survival was 86.26% in the capecitabine group...
News
- Author:
- Will Pass
Publish date: December 12, 2019
SAN ANTONIO – There was no statistically significant difference in 10-year ipsilateral breast tumor recurrence between those who received accelerat...
News
- Author:
- Will Pass
Publish date: December 12, 2019
In a meta-analysis of data on more than 15,000 patients with early-stage breast cancer, adding capecitabine to systemic treatment resulted in a 22%...
News
- Author:
- Will Pass
Publish date: December 12, 2019
SAN ANTONIO – The 5-year invasive disease-free survival was 86.9% among patients who received endocrine therapy plus S-1, compared with 81.6% for p...
News
- Author:
- Will Pass
Publish date: December 6, 2019
At week 18 in KEYNOTE-407, more patients in the pembrolizumab plus chemotherapy group reported improvements in health-related quality of life, comp...
News
- Author:
- Will Pass
Publish date: December 4, 2019
The drug showed advantages over targeted monotherapies but was similar to rituximab-based combinations.
News
- Author:
- Will Pass
Publish date: December 3, 2019
In the presence of an oncogene, E-cadherin may play a pivotal role in pancreatic tumor formation.
News
- Author:
- Will Pass
Publish date: December 2, 2019
A single-use duodenoscope may reduce the risk of endoscopy-related infection while maintaining a high level of user satisfaction.
News
- Author:
- Will Pass
Publish date: December 1, 2019
A minimally invasive approach focusing on percutaneous drainage and/or endoscopic drainage or debridement is now favored over surgery.
News
- Author:
- Will Pass
Publish date: December 1, 2019
New clinical practice guidelines from the Canadian Association of Gastroenterology focus on the management of bile acid diarrhea.
News
- Author:
- Will Pass
Publish date: December 1, 2019
The Canadian Association of Gastroenterology (CAG) recently published a clinical practice guideline for the management of bile acid di...
